RankingsPricing
  1. US-listed companies
  2. WEST PHARMACEUTICAL SERVICES INC
  3. Financials
  4. Cash and cash equivalents

WEST PHARMACEUTICAL SERVICES INCWST

Market cap
$19.5B
P/E ratio
SummaryFinancials
Period EndCash and cash equivalents (Million USD)YoY (%)
Dec 31, 2024485-43.25%
Dec 31, 2023854-4.52%
Dec 31, 2022894+17.27%
Dec 31, 2021763+23.90%
Dec 31, 2020616+40.17%
Dec 31, 2019439+30.14%
Dec 31, 2018337+43.03%
Dec 31, 2017236+16.21%
Dec 31, 2016203-26.07%
Dec 31, 2015275+7.56%
Dec 31, 2014255+11.00%
Dec 31, 2013230+42.06%
Dec 31, 2012162+46.91%
Dec 31, 2010110

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)